<DOC>
	<DOC>NCT01617720</DOC>
	<brief_summary>This Study is designed to observe the clinical outcomes of patients requiring mitral repair that were treated with the CE certified Cardinal System.</brief_summary>
	<brief_title>MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)</brief_title>
	<detailed_description />
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Age &gt; 18 years Patient is a candidate for mitral valve repair, with our without concomitant procedures. Subject is willing to give informed consent for collection of his/her clinical data. Severe organic lesions with retracted chordae Congenital malformations with lack of valvular tissue Severe valvular calcifications Evolving bacterial endocarditis Known Sensitivity to Nickel or Chromium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>mitral</keyword>
	<keyword>valve</keyword>
	<keyword>annuloplasty</keyword>
	<keyword>mitral regurgitation</keyword>
</DOC>